openPR Logo
Press release

Generic Injectables Market Size, Analysis, Growth Factors, Report 2023-2028

12-27-2023 07:23 AM CET | Health & Medicine

Press release from: IMARC Group

Generic Injectables Market

Generic Injectables Market

The latest report published by IMARC Group, titled "Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a comprehensive analysis of the industry, which comprises insights on generic injectables market. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global generic injectables market size reached US$ 43.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 70.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.

Get a Sample Copy of this Report: https://www.imarcgroup.com/generic-injectables-market/requestsample

Factors Affecting the Growth of the Generic Injectables Industry:

• Cost-Effectiveness of Injectables:

A primary factor driving the global generic injectables market is the cost-effectiveness of generic drugs compared to their branded counterparts. Generic injectables offer a more affordable alternative for healthcare systems and patients, particularly in treating chronic conditions and in markets with high price sensitivity. The lower price point is due to reduced research and development costs, as generic manufacturers do not bear the initial expenses of developing new drugs. This affordability not only improves patient access to essential medications but also reduces the financial burden on healthcare systems, making generic injectables a preferred choice in both developed and emerging markets.

• Increasing Patent Expirations:

The rise in the global generic injectables market is significantly fueled by the expiration of patents for several blockbuster drugs. When patents expire, it opens the door for generic manufacturers to produce bioequivalent versions, often leading to a sharp increase in market competition and a corresponding decrease in prices. This transition plays a crucial role in the healthcare sector, as it facilitates the availability of essential drugs at a lower cost. In addition, the patent cliff, particularly in the biologics segment is prompting a robust growth in the biosimilars market, further expanding the scope and reach of generic injectables globally.

• Growing Prevalence of Chronic Diseases:

The escalating prevalence of chronic diseases worldwide is a critical driver for the generic injectables market. Chronic conditions such as diabetes, cardiovascular diseases, and various cancers require ongoing treatment, often necessitating the use of injectable drugs for effective management. In addition, the growing patient pool for these diseases creates a sustained demand for affordable treatment options, thus bolstering the market for generic injectables. Moreover, the aging global population, more prone to chronic illnesses, further amplifies this demand, making generic injectables an essential component in global healthcare management. This trend underscores the importance of generic injectables in providing cost-effective, long-term treatments for chronic health conditions.

Explore Full Report with Table of Contents: https://www.imarcgroup.com/generic-injectables-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Hospira (Pfizer)
• Fresenius Kabi
• Hikma
• Sandoz (Novartis)
• Sagent
• Sanofi
• Baxter

Generic Injectables Market Report Segmentation:

Breakup by Therapeutic Area:

• Oncology
• Anaesthesia
• Anti-infectives
• Parenteral Nutrition
• Cardiovascular

Oncology represents the largest segment due to the rising global incidence of various types of cancers, necessitating an increased demand for oncology drugs, many of which are administered via injectables for effective treatment.

Breakup by Container:

• Vials
• Ampoules
• Premix
• Prefilled Syringes

Vials are the most commonly used container for generic injectables due to their cost-effectiveness, ease of handling, and suitability for a wide range of liquid drug formulations, making them a practical choice for healthcare providers.

Breakup by Distribution Channel:

• Hospitals
• Retail Pharmacy

Hospitals are the primary distribution channel for generic injectables due to the immediate requirement and administration of these drugs in a controlled healthcare setting, particularly for acute care and chronic disease management.

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

North America leads in the generic injectables market due to its advanced healthcare infrastructure, high healthcare spending, stringent regulatory policies ensuring drug quality, and the presence of key pharmaceutical players in this region.

Global Generic Injectables Market Trends:

The increasing focus on complex injectables, such as high-potency active pharmaceutical ingredients (HPAPIs) and long-acting formulations is favoring the market. These complex products offer higher margins for manufacturers and are less likely to face intense competition, unlike standard generics. Additionally, there's a growing emphasis on oncology injectables, driven by a rise in cancer incidence globally. This trend is leading to a surge in demand for chemotherapy and supportive care drugs in injectable form.

Furthermore, advancements in drug delivery technologies are enhancing the stability and efficacy of generic injectables, making them more appealing to both healthcare providers and patients. These trends, combined with regulatory support for generic drug approvals, particularly in high-burden healthcare markets, are further propelling the growth of the market.

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Generic Injectables Market Size, Analysis, Growth Factors, Report 2023-2028 here

News-ID: 3338440 • Views:

More Releases from IMARC Group

India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insights
India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insig …
As indicated in the latest market research report published by IMARC Group, titled "India Seafood Market Report by Type (Fish, Shrimps, Others), Form (Fresh/Chilled, Frozen/Canned, Processed), Distribution Channel (Off Trade, On Trade), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market. Market Size & Future Growth Potential: The India seafood
India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025-2033
India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025 …
Mutual Funds Market in India 2025: Base Year: 2024 Historical Years: 2019-2024 Forecast Years: 2025-2033 Market Size in 2024: USD 2.50 Billion Market Size in 2033: USD 5.90 Billion Market Growth Rate (CAGR) 2025-2033: 10.03% How Big is the India Mutual Funds Industry? The India mutual funds market size reached USD 2.50 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.90 Billion by 2033, exhibiting a growth rate (CAGR) of 10.03% during 2025-2033. Request
Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Expanding at a CAGR of 8.09%
Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Ex …
Market Overview: The dimethyl ether market is experiencing significant growth momentum, driven by increasing demand for cleaner fuel alternatives, expanding applications in various industries, and supportive government policies promoting sustainable energy solutions. According to IMARC Group's latest research publication, "Dimethyl Ether Market Size, Share, Trends and Forecast by Raw Material, Application, End-Use Industry, and Region, 2025-2033", the global dimethyl ether market size reached USD 7.22 Billion in 2024. Looking forward, IMARC
Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, Project Economics
Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, P …
Setting up a glucometer manufacturing plant requires thorough market research alongside a minute understanding of numerous operating factors such as unit processes, purchasing of raw materials, utility supply, infrastructure creation, equipment and technology specifications, human resource planning, logistics, and cash outlay. IMARC Group's report titled "Glucometer Manufacturing Plant Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a

All 5 Releases


More Releases for Generic

Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth? The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall. Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs. The global generic drugs market is driven by the rise of
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems. At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of